Abnormal barrier function due to filaggrin gene mutations was confirmed in patients with AD or AA, and filaggrin gene mutations have been shown to increase the risk of developing early and severe AD, as well as AA in patients with AD [28]. The gene discussed is FLG; the disease is Alzheimer disease.